Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nadezhda, Malomanova"'
Autor:
Yanina Balabanova, Vladyslav Nikolayevskyy, Olga Ignatyeva, Irina Kontsevaya, Clare M Rutterford, Anastasiya Shakhmistova, Nadezhda Malomanova, Yulia Chinkova, Svetlana Mironova, Ivan Fedorin, Francis A Drobniewski
Publikováno v:
PLoS ONE, Vol 6, Iss 6, p e20531 (2011)
OBJECTIVE AND METHODS: A long-term observational study was conducted in Samara, Russia to assess the survival and risk factors for death of a cohort of non-multidrug resistant tuberculosis (non-MDRTB) and multidrug resistant tuberculosis (MDRTB) civi
Externí odkaz:
https://doaj.org/article/7fc3ab9242124c0c93e98b29866da3ad
Autor:
Yanina Balabanova, Francis Drobniewski, Vladyslav Nikolayevskyy, Annika Kruuner, Nadezhda Malomanova, Tatyana Simak, Nailya Ilyina, Svetlana Zakharova, Natalya Lebedeva, Heather L Alexander, Rick O'Brien, Hojoon Sohn, Anastasia Shakhmistova, Ivan Fedorin
Publikováno v:
PLoS ONE, Vol 4, Iss 9, p e7129 (2009)
ObjectiveTo analyse the feasibility, cost and performance of rapid tuberculosis (TB) molecular and culture systems, in a high multidrug-resistant TB (MDR TB) middle-income region (Samara, Russia) and provide evidence for WHO policy change.MethodsPerf
Externí odkaz:
https://doaj.org/article/96a78f8c3f25405b868d9755bf8517d4
Autor:
Vladyslav, Nikolayevskyy, Yanina, Balabanova, Tatyana, Simak, Nadezhda, Malomanova, Ivan, Fedorin, Francis, Drobniewski
Publikováno v:
BMC Clinical Pathology, Vol 9, Iss 1, p 2 (2009)
BMC Clinical Pathology
BMC Clinical Pathology
Background Russia is a high tuberculosis (TB) burden country with a high prevalence of multidrug resistant tuberculosis (MDRTB). Molecular assays for detection of MDRTB on clinical specimens are not widely available in Russia. Results We performed an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::645c71c1f21ffa994f88f67a6854d87d
http://www.biomedcentral.com/1472-6890/9/2
http://www.biomedcentral.com/1472-6890/9/2
Autor:
Tatyana Simak, Francis Drobniewski, Vladyslav Nikolayevskyy, Ivan Fedorin, Yanina Balabanova, Nadezhda Malomanova
Publikováno v:
BMC Clinical Pathology. 9(1)
Background Russia is a high tuberculosis (TB) burden country with a high prevalence of multidrug resistant tuberculosis (MDRTB). Molecular assays for detection of MDRTB on clinical specimens are not widely available in Russia. Results We performed an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::621ddc47f03e8094721106bc1d9f0b85